3 Powerful Nuclear Energy Stocks to Buy in May

Bank of America sees nuclear energy as a "rediscovered" growth theme amid surging electricity demand, citing SMRs for lower upfront costs, enhanced safety, and reduced CO2 output. The article highlights NuScale Power and Oklo as the main SMR plays, while noting SpaceX could gain indirect nuclear exposure if orbital data centers develop and the company goes public. The piece is constructive for nuclear-related names, but it is largely thematic commentary rather than a catalyst with immediate price impact.

Analysis

The market is still pricing SMR as a technology option, but the real value inflection is likely to come from permitting, fabrication capacity, and financing rather than reactor physics. That favors the names with the clearest path to contracted backlog and repeatable deployment, while punishing “science project” valuations if timelines slip by even 12-18 months. In practice, the first winners are likely to be the companies that can secure anchor customers and manufacturing partners, not necessarily the first to demonstrate a technical milestone.

OKLO has a more compelling near-term commercialization profile because smaller, bespoke deployments can match the procurement behavior of hyperscalers and industrial campuses; that creates a shorter sales cycle and more optionality around behind-the-meter power. SMR, by contrast, needs utility-scale conviction and grid interconnection progress, which means the equity remains more sensitive to rate moves and project execution than to broad AI enthusiasm. If capital markets tighten, OKLO’s customer-funded model should hold up better than utility-led megaproject economics.

The second-order beneficiary is the nuclear supply chain: engineering, controls, fuel handling, and component fabrication should get the first durable earnings upgrade, while pure-play reactor equities may stay headline-driven. If data-center operators start treating power as a strategic constraint, the trade shifts from “buy nuclear beta” to “own the bottleneck providers,” especially those with regulated or quasi-regulated cash flows. SpaceX is the most speculative expression of the theme; its nuclear linkage is long-dated and should be valued as optionality, not a core fundamental driver.

The contrarian setup is that the narrative is outrunning the delivery curve. The public market is likely to overestimate how quickly SMRs become investable assets and underestimate how much of the near-term upside is already embedded in multiple expansion. Any policy delay, cost overrun, or higher-for-longer rate regime could compress sentiment fast, especially in the pre-revenue names where funding needs are most exposed.

Key Decisions for Investors

• Long OKLO / short SMR as a 6-12 month relative-value pair: OKLO has better commercialization optionality and a shorter path to customer validation, while SMR remains more exposed to utility-cycle delays and financing risk.
• Buy a starter long in SMR only on 15-20% pullbacks, ideally after execution headlines fade; use a 12-month horizon and size it as an option on policy/utility adoption rather than a core equity position.
• Prefer the nuclear picks-and-shovels basket over reactor equities: overweight suppliers tied to fuel cycle, controls, and fabrication on any weakness, because margin expansion will likely show up there first over the next 12-24 months.
• Avoid chasing SpaceX as a nuclear proxy until post-IPO disclosures clarify capital allocation; treat the thesis as a long-dated call option, not a near-term catalyst.
• For upside exposure with defined risk, consider out-of-the-money 12-18 month calls on OKLO rather than outright equity if implied volatility remains below realized project-news volatility.